{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:37:09Z","timestamp":1792273029115,"version":"4.4.0"},"reference-count":64,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T00:00:00Z","timestamp":1376870400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0063972","type":"journal-article","created":{"date-parts":[[2013,8,19]],"date-time":"2013-08-19T17:24:49Z","timestamp":1376933089000},"page":"e63972","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":302,"title":["Psychedelics and Mental Health: A Population Study"],"prefix":"10.1371","volume":"8","author":[{"given":"Teri S.","family":"Krebs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l-\u00d8rjan","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,8,19]]},"reference":[{"key":"ref1","unstructured":"McGlothlin WH (1964) Hallucinogenic Drugs: A Perspective with Special Reference to Peyote and Cannabis. RAND Corp. Available: http:\/\/www.rand.org\/pubs\/papers\/P2937.html<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0140-6736(02)08701-9","article-title":"Mescaline use for 5700 years","volume":"359","author":"JG Bruhn","year":"2002","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.pharmthera.2003.11.002","article-title":"Hallucinogens","volume":"101","author":"DE Nichols","year":"2004","journal-title":"Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Krebs TS, Johansen P\u00d8 (2013) Over 30 million psychedelic users in the United States. F1000 Research (in press).","DOI":"10.12688\/f1000research.2-98.v1"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Hallock RM, Dean A, Knecht ZA, Spencer J, Taverna EC (2012) A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. Drug Alcohol Depend. 2012 Dec 19 [Epub ahead of print]. pii: S0376-8716(12)00451-6. doi:10.1016\/j.drugalcdep.2012.11.010.","DOI":"10.1016\/j.drugalcdep.2012.11.010"},{"key":"ref6","unstructured":"Briggs G, Freeman RK, Sumner JY (2011) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. 9th ed. Lippincott Williams & Wilkins."},{"key":"ref7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archpsyc.1971.01750070037005","article-title":"LSD revisited. A ten-year follow-up of medical LSD use","volume":"24","author":"WH McGlothlin","year":"1971","journal-title":"Arch Gen Psychiatry"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"R Griffiths","year":"2008","journal-title":"J Psychopharmacol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"RR Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0269881109106915","article-title":"Harms associated with psychoactive substances: findings of the UK National Drug Survey","volume":"24","author":"CJA Morgan","year":"2010","journal-title":"J Psychopharmacol"},{"key":"ref11","first-page":"283","article-title":"User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study","volume":"15","author":"RL Carhart-Harris","year":"2010","journal-title":"J Subst Abuse"},{"key":"ref12","first-page":"1","article-title":"Pahnke\u2019s \u201cGood Friday Experiment\u201d: a long-term follow-up and methodological critique","volume":"23","author":"R Doblin","year":"1991","journal-title":"J Transpersonal Psy"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1037\/h0034411","article-title":"Long-term psychological effects of LSD","volume":"79","author":"SA McWilliams","year":"1973","journal-title":"Psychol Bull"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.addbeh.2003.08.033","article-title":"Drugs of abuse and the elicitation of human aggressive behavior","volume":"28","author":"PNS Hoaken","year":"2003","journal-title":"Addict Behav"},{"key":"ref15","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2011) Drug Profiles: Lysergide (LSD). Available: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/lsd<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"D Nutt","year":"2007","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"DJ Nutt","year":"2010","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000317249","article-title":"Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population","volume":"16","author":"J Van Amsterdam","year":"2010","journal-title":"Eur Addict Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e000774","DOI":"10.1136\/bmjopen-2011-000774","article-title":"Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across Scotland","volume":"2","author":"M Taylor","year":"2012","journal-title":"BMJ Open"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1177\/0269881110382466","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","volume":"25","author":"E Studerus","year":"2011","journal-title":"J Psychopharmacol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"J Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"ref22","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental health disorders. 4th ed. Washington DC: American Psychiatric Association."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/archpsyc.60.2.184","article-title":"Screening for serious mental illness in the general population","volume":"60","author":"RC Kessler","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00127-010-0247-6","article-title":"Measuring the level of diagnostic concordance and discordance between modules of the CIDI-Short Form and the CIDI-Auto 2.1","volume":"46","author":"M Sunderland","year":"2011","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref25","unstructured":"International Consortium in Psychiatric Epidemiology (2005) Appendix for \u201cNew Scales to Screen for Serious Mental Illness in the General Population\u201d. Available: http:\/\/www.hcp.med.harvard.edu\/icpe\/smi_appendix.php<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref26","unstructured":"Patel V, Lund C, Hatherill S, Plagerson S, Corrigall J, et al<\/etal>.. (2010) Mental disorders: equity and social determinants. In: Blas E, Sivasankara Kurup A, editors. Equity, social determinants and public health programmes. World Health Organization. pp.115\u2013134."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"E Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Catts VS, Catts SV (2010) Psychotomimetic effects of PCP, LSD, and Ecstasy: pharmacological models of schizophrenia? In: Sachdev PS, Keshavan MS, editors. Secondary Schizophrenia. Cambridge University Press. pp.141\u2013168.","DOI":"10.1017\/CBO9780511789977.011"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yrtph.2011.01.006","article-title":"Harm potential of magic mushroom use: a review","volume":"59","author":"J Van Amsterdam","year":"2011","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref30","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (2011) Drug Profiles: Hallucinogenic Mushrooms. Available: http:\/\/www.emcdda.europa.eu\/publications\/drug-profiles\/mushrooms<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref31","unstructured":"National Institute on Drug Abuse (2009) DrugFacts: Hallucinogens - LSD, Peyote, Psilocybin, and PCP. Available: http:\/\/www.drugabuse.gov\/publications\/drugfacts\/hallucinogens-lsd-peyote-psilocybin-pcp<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref32","unstructured":"United Nations Office on Drugs and Crime (2012) Get the Facts: Hallucinogens. Available: http:\/\/www.unodc.org\/drugs\/en\/get-the-facts\/hallucinogens.html<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref33","unstructured":"Department of Health and the Home Office (2012) LSD. FRANK Drug Awareness Campaign. Available: http:\/\/www.talktofrank.com\/drug\/LSD<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref34","unstructured":"Department of Health and the Home Office (2012) Magic Mushrooms. FRANK Drug Awareness Campaign. Available: http:\/\/www.talktofrank.com\/drug\/magic-mushrooms<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref35","first-page":"59","article-title":"The recanting of earlier reported drug use by young adults","volume":"167","author":"LD Johnston","year":"1997","journal-title":"NIDA Res Monogr"},{"key":"ref36","unstructured":"Laing R, Siegel JA, editors (2003) Hallucinogens: A Forensic Drug Handbook. Academic Press."},{"key":"ref37","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.biopsych.2005.06.038","article-title":"Psychological and cognitive effects of long-term peyote use among Native Americans","volume":"58","author":"JH Halpern","year":"2005","journal-title":"Biol Psychiatry"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"e42421","DOI":"10.1371\/journal.pone.0042421","article-title":"Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of ayahuasca: a longitudinal study","volume":"7","author":"JC Bouso","year":"2012","journal-title":"PLoS One"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1600-0447.2010.01633.x","article-title":"Associations between use of cocaine, amphetamines, or psychedelics and psychotic symptoms in a community sample","volume":"123","author":"N Kuzenko","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.janxdis.2006.09.014","article-title":"Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample","volume":"21","author":"MO Bonn-Miller","year":"2007","journal-title":"J Anxiety Disord"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.1983.01790070067008","article-title":"LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry","volume":"40","author":"MM Vardy","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archpsyc.1983.01790070074009","article-title":"Visual phenomenology of the LSD flashback","volume":"40","author":"HD Abraham","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1300\/J069v18n02_06","article-title":"LSD use and flashbacks in alcoholic patients","volume":"18","author":"W Batzer","year":"1999","journal-title":"J Addict Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.2044-8341.2011.02024.x","article-title":"Prevalence and correlates of anomalous experiences in a large non-clinical sample","volume":"85","author":"R Pechey","year":"2012","journal-title":"Psychol Psychother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2466\/pms.110.3c.1125-1138","article-title":"Apparitional experiences of new faces and dissociation of self-identity during mirror gazing","volume":"110","author":"GB Caputo","year":"2010","journal-title":"Percept Mot Skills"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0165-1781(00)00227-4","article-title":"Prevalence of hallucinations and their pathological associations in the general population","volume":"97","author":"MM Ohayon","year":"2000","journal-title":"Psychiatry Res"},{"key":"ref47","unstructured":"Schankin CJ, Maniyar F, Goadsby PJ (2012) Field-testing the criteria for \u201cvisual snow\u201d (positive persistent visual disturbance). F1000 Posters 3. Available: http:\/\/f1000.com\/posters\/browse\/summary\/1090714<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref48","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0376-8716(02)00306-X","article-title":"Hallucinogen persisting perception disorder: What do we know after 50 years?","volume":"69","author":"JH Halpern","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpsychores.2012.08.020","article-title":"Predictive validity and clinical utility of DSM-5 Somatic Symptom Disorder - Comparison with DSM-IV somatoform disorders and additional criteria for consideration","volume":"73","author":"K Voigt","year":"2012","journal-title":"J Psychosomatic Res"},{"key":"ref50","unstructured":"Genova P (2002) The Permanent Trip. The Thaw: Reclaiming the Person for Psychiatry. Hillsdale, NJ: Analytic Press. pp.17\u201319."},{"key":"ref51","unstructured":"Henderson LA (1998) Adverse reaction to LSD. LSD: Still with us after all these years. San Francisco, CA: Jossey-Bass. pp.55\u201375."},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Andersson C, Kristinsson J, Gry J (2009) Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids. Nordic Council of Ministers. Available: http:\/\/www.norden.org\/en\/publications\/publikationer\/2008-606\/<\/ext-link>. Accessed 2013 Apr 30.","DOI":"10.6027\/tn2008-606"},{"key":"ref53","unstructured":"Aberle DF (1991) The Peyote Religion Among the Navaho. 2nd ed. University of Oklahoma Press."},{"key":"ref54","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1176\/ajp.128.6.695","article-title":"Navajo peyote use: its apparent safety","volume":"128","author":"RL Bergman","year":"1971","journal-title":"Am J Psychiatry"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"J Per\u00e4l\u00e4","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.pbb.2007.06.001","article-title":"Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action","volume":"87","author":"D Marona-Lewicka","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"ref57","unstructured":"Garden M (2007) Can meditation be bad for you? The Humanist. Available: http:\/\/www.thehumanist.org\/humanist\/MaryGarden.html<\/ext-link>. Accessed 2013 Apr 30."},{"key":"ref58","first-page":"62","article-title":"Adverse effects of meditation: a preliminary investigation of long-term meditators","volume":"39","author":"DH Shapiro Jr","year":"1992","journal-title":"Int J Psychosom"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000108125","article-title":"Meditation-induced psychosis","volume":"40","author":"HJH Kuijpers","year":"2007","journal-title":"Psychopathology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1192\/bjp.178.4.380-b","article-title":"Soviet-style psychiatry is alive and well in the People\u2019s Republic","volume":"178","author":"D Lyons","year":"2001","journal-title":"Br J Psychiatry"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1192\/bjp.179.2.178-a","article-title":"Who is politicising psychiatry in China?","volume":"179","author":"S Lee","year":"2001","journal-title":"Br J Psychiatry"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1192\/bjp.176.1.86","article-title":"Jerusalem syndrome","volume":"176","author":"Y Bar-el","year":"2000","journal-title":"Br J Psychiatry"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1192\/bjp.176.5.492-a","article-title":"Comments on Jerusalem syndrome","volume":"176","author":"M Kalian","year":"2000","journal-title":"Br J Psychiatry"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Nicholson TRJ, Pariante C, McLoughlin D (2009) Stendhal syndrome: a case of cultural overload. BMJ Case Reports 2009: pii: bcr06.2008.0317.","DOI":"10.1136\/bcr.06.2008.0317"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0063972","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T01:06:15Z","timestamp":1540256775000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0063972"}},"subtitle":[],"editor":[{"given":"Lin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,8,19]]},"references-count":64,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,8,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0063972","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,19]]}}}